{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:36:45Z","timestamp":1785775005259,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["820820"],"award-info":[{"award-number":["820820"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is a common cause of disability in working age adults. Current clinical assessments are inadequate at disability assessment or predicting clinically relevant outcomes. Loss of mobility is an important functional disability to people with MS. Mobilise-D aims to develop, validate, and implement a digital mobility solution which measures unsupervised mobility performance across several chronic conditions, including MS, using a single wearable device.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six hundred two adults with MS, an Expanded Disability Status Scale (EDSS) score of 3.0\u20136.5, documented disability worsening over the previous 2\u00a0years and a 30-day freedom from relapses, were recruited across four European centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1416 invited, 602 participants (42%) were recruited. Primary recruitment sources were clinicians (42%) and local registries (42%). Among 616 who declined screening, the main reasons were a lack of interest (44%), the time commitment (25%) or the travel involved (13%). Participants had a mean age of 52\u00a0years; 64% were female, with a median EDSS score of 5.0. Of those, 56% had relapsing-remitting MS, 33% secondary progressive MS and 10% primary progressive MS. Falls occurred in 58% of participants in the 12\u00a0months prior to recruitment. Of those recruited, 556 (93%) participants had valid mobility data recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The longitudinal collection of clinical and unsupervised mobility assessments will provide a comprehensive dataset, allowing for the determination of digital mobility assessments\u2019 construct validity, predictive capacity, responsiveness, and clinical meaningfulness. Novel insights into real-world mobility that describe both walking activity and gait outcomes will be gained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was registered at the ISRCTN registry on 12\/10\/2020, titled \u201cClinical validation of a mobility monitor to measure and predict health outcomes\u201d (ISRCTN Number: 12051706).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09404-6","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:06:20Z","timestamp":1768629980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study\u2014lessons learnt, baseline demographics and clinical characteristics"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-7203","authenticated-orcid":false,"given":"Gavin","family":"Brittain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Lanfranchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanos","family":"Tsaktanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Rothhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klarissa Hanja","family":"St\u00fcrner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Maetzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Rochester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Neatrour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Vereijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joren","family":"Buekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Garcia-Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Armengol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Gassner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Philipp","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Leocani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Brichetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Dallas","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Sharrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"9404_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816\u201321. https:\/\/doi.org\/10.1177\/1352458520970841.","journal-title":"Mult Scler"},{"key":"9404_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, et al. Multiple sclerosis. Lancet. 2024;403:183\u2013202. https:\/\/doi.org\/10.1016\/s0140-6736(23)01473-3.","journal-title":"Lancet"},{"key":"9404_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7224\/1537-2073.2018-087","volume":"22","author":"AD Bass","year":"2020","unstructured":"Bass AD, et al. Effect of Multiple Sclerosis on Daily Activities, Emotional Well-being, and Relationships: The Global vsMS Survey. Int J MS Care. 2020;22:158\u201364. https:\/\/doi.org\/10.7224\/1537-2073.2018-087.","journal-title":"Int J MS Care"},{"key":"9404_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/1352458508088916","volume":"14","author":"C Heesen","year":"2008","unstructured":"Heesen C, et al. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler J. 2008;14:988\u201391. https:\/\/doi.org\/10.1177\/1352458508088916.","journal-title":"Mult Scler J"},{"key":"9404_CR5","first-page":"127","volume":"4","author":"K Edgley","year":"1991","unstructured":"Edgley K, Sullivan MJ, Dehoux E. A survey of multiple sclerosis: II. determinants of employment status. Can J Rehabil. 1991;4:127\u201332.","journal-title":"Can J Rehabil"},{"key":"9404_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/003435520104500104","volume":"45","author":"RT Roessler","year":"2001","unstructured":"Roessler RT, Fitzgerald SM, Rumrill PD, Koch LC. Determinants of employment status among people with multiple sclerosis. Rehabil Counsel Bull. 2001;45:31\u20139. https:\/\/doi.org\/10.1177\/003435520104500104.","journal-title":"Rehabil Counsel Bull"},{"key":"9404_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/a:1025450526334","volume":"10","author":"MP McCabe","year":"2003","unstructured":"McCabe MP, De Judicibus M. <article-title update=\"added\">Multiple sclerosis and economic well-being: role of health, age, and duration of illness. J Clin Psychol Med Settings. 2003;10:139\u201347. https:\/\/doi.org\/10.1023\/a:1025450526334.","journal-title":"J Clin Psychol Med Settings"},{"issue":"8","key":"9404_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/jnnp.2006.090365","volume":"77","author":"G Kobelt","year":"2006","unstructured":"Kobelt G. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006;77(8):918\u201326. https:\/\/doi.org\/10.1136\/jnnp.2006.090365.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9404_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s12325-009-0082-x","volume":"26","author":"HL Zwibel","year":"2009","unstructured":"Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Adv Ther. 2009;26:1043\u201357. https:\/\/doi.org\/10.1007\/s12325-009-0082-x.","journal-title":"Adv Ther"},{"key":"9404_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/brain\/122.1.141","volume":"122","author":"B Sharrack","year":"1999","unstructured":"Sharrack B, Hughes RAC, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain. 1999;122:141\u201359. https:\/\/doi.org\/10.1093\/brain\/122.1.141.","journal-title":"Brain"},{"key":"9404_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/135245850100700206","volume":"7","author":"H Albrecht","year":"2001","unstructured":"Albrecht H, et al. Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter. Mult Scler. 2001;7:105\u20139. https:\/\/doi.org\/10.1177\/135245850100700206.","journal-title":"Mult Scler"},{"key":"9404_CR12","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/brain\/123.5.1027","volume":"123","author":"J Hobart","year":"2000","unstructured":"Hobart J. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain. 2000;123:1027\u201340. https:\/\/doi.org\/10.1093\/brain\/123.5.1027.","journal-title":"Brain"},{"key":"9404_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1212\/wnl.60.1.31","volume":"60","author":"JC Hobart","year":"2003","unstructured":"Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12). Neurology. 2003;60:31\u20136. https:\/\/doi.org\/10.1212\/wnl.60.1.31.","journal-title":"Neurology"},{"key":"9404_CR14","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s11136-021-02802-8","volume":"30","author":"C Blome","year":"2021","unstructured":"Blome C, et al. How to measure fluctuating impairments in people with MS: development of an ambulatory assessment version of the EQ-5D-5L in an exploratory study. Qual Life Res. 2021;30:2081\u201396. https:\/\/doi.org\/10.1007\/s11136-021-02802-8.","journal-title":"Qual Life Res"},{"key":"9404_CR15","unstructured":"European Medicines Agency. Qualification opinion on Multiple sclerosis clinical outcome assessment (MSCOA). (2020)."},{"key":"9404_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-021-00513-5","author":"A Polhemus","year":"2021","unstructured":"Polhemus A, et al. Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes. NPJ Digit Med. 2021. https:\/\/doi.org\/10.1038\/s41746-021-00513-5.","journal-title":"NPJ Digit Med"},{"key":"9404_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1177\/13524585231189677","volume":"29","author":"RA Marrie","year":"2023","unstructured":"Marrie RA, et al. Enhancing diversity of clinical trial populations in multiple sclerosis. Mult Scler. 2023;29:1174\u201385. https:\/\/doi.org\/10.1177\/13524585231189677.","journal-title":"Mult Scler"},{"issue":"8","key":"9404_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler J. 2017;23(8):1123\u201336. https:\/\/doi.org\/10.1177\/1352458517694432.","journal-title":"Mult Scler J"},{"key":"9404_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000512513","volume":"4","author":"L Rochester","year":"2020","unstructured":"Rochester L, et al. A roadmap to inform development, validation and approval of digital mobility outcomes: the Mobilise-D approach. Digit Biomark. 2020;4:13\u201327. https:\/\/doi.org\/10.1159\/000512513.","journal-title":"Digit Biomark"},{"key":"9404_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050785","volume":"11","author":"C Mazz\u00e0","year":"2021","unstructured":"Mazz\u00e0 C, et al. Technical validation of real-world monitoring of gait: a multicentric observational study. BMJ Open. 2021;11:e050785. https:\/\/doi.org\/10.1136\/bmjopen-2021-050785.","journal-title":"BMJ Open"},{"key":"9404_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/20552076221150745","volume":"9","author":"A Keogh","year":"2023","unstructured":"Keogh A, et al. Acceptability of wearable devices for measuring mobility remotely: observations from the Mobilise-D technical validation study. DIGITAL HEALTH. 2023;9:20552076221150745. https:\/\/doi.org\/10.1177\/20552076221150745.","journal-title":"DIGITAL HEALTH"},{"key":"9404_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12984-023-01198-5","volume":"20","author":"ME Mic\u00f3-Amigo","year":"2023","unstructured":"Mic\u00f3-Amigo ME, et al. Assessing real-world gait with digital technology? Validation, insights and recommendations from the Mobilise-D consortium. J Neuroeng Rehabil. 2023;20:78. https:\/\/doi.org\/10.1186\/s12984-023-01198-5.","journal-title":"J Neuroeng Rehabil"},{"key":"9404_CR23","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/s41598-024-51766-5","volume":"14","author":"C Kirk","year":"2024","unstructured":"Kirk C, et al. Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device. Sci Rep. 2024;14:1754. https:\/\/doi.org\/10.1038\/s41598-024-51766-5.","journal-title":"Sci Rep"},{"key":"9404_CR24","doi-asserted-by":"publisher","unstructured":"Mikolaizak, A. S. et al. Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement \u2013 the Mobilise-D study protocol. medRxiv, 2022.2005.2025.22275598, https:\/\/doi.org\/10.1101\/2022.05.25.22275598 (2022).","DOI":"10.1101\/2022.05.25.22275598"},{"key":"9404_CR25","doi-asserted-by":"publisher","DOI":"10.2196\/44206","volume":"25","author":"A Keogh","year":"2023","unstructured":"Keogh A, et al. Mobilizing patient and public involvement in the development of real-world digital technology solutions: tutorial. J Med Internet Res. 2023;25:e44206. https:\/\/doi.org\/10.2196\/44206.","journal-title":"J Med Internet Res"},{"issue":"2","key":"9404_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373. https:\/\/doi.org\/10.1016\/s1474-4422(17)30470-2.","journal-title":"Lancet Neurol"},{"key":"9404_CR27","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u20131444. https:\/\/doi.org\/10.1212\/wnl.33.11.1444.","journal-title":"Neurology"},{"key":"9404_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ana.410400321","volume":"40","author":"R Rudick","year":"1996","unstructured":"Rudick R, et al. Clinical outcomes assessment in multiple sclerosis. Ann Neurol. 1996;40:469\u201379. https:\/\/doi.org\/10.1002\/ana.410400321.","journal-title":"Ann Neurol"},{"key":"9404_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103438","volume":"57","author":"DM Oosterveer","year":"2022","unstructured":"Oosterveer DM, et al. Determining the minimal important change of the 6-minute walking test in Multiple Sclerosis patients using a predictive modelling anchor-based method. Mult Scler Relat Disord. 2022;57:103438. https:\/\/doi.org\/10.1016\/j.msard.2021.103438.","journal-title":"Mult Scler Relat Disord"},{"key":"9404_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.23736\/s1973-9087.18.05366-2","volume":"55","author":"M Valet","year":"2019","unstructured":"Valet M, et al. Timed up-and-go and 2-minute walk test in patients with multiple sclerosis with mild disability: reliability, responsiveness and link with perceived fatigue. Eur J Phys Rehabil Med. 2019;55:450\u20135. https:\/\/doi.org\/10.23736\/s1973-9087.18.05366-2.","journal-title":"Eur J Phys Rehabil Med"},{"key":"9404_CR31","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.m85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-94. https:\/\/doi.org\/10.1093\/geronj\/49.2.m85.","journal-title":"J Gerontol"},{"key":"9404_CR32","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1352458517690822","volume":"23","author":"LJ Balcer","year":"2017","unstructured":"Balcer LJ, et al. Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis. Mult Scler. 2017;23:734\u201347. https:\/\/doi.org\/10.1177\/1352458517690822.","journal-title":"Mult Scler"},{"key":"9404_CR33","doi-asserted-by":"crossref","unstructured":"Smith, A. Symbol digit modalities test. The Clinical Neuropsychologist (1973).","DOI":"10.1037\/t27513-000"},{"key":"9404_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1212\/wnl.45.2.251","volume":"45","author":"MJ Hohol","year":"1995","unstructured":"Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995;45:251\u20135. https:\/\/doi.org\/10.1212\/wnl.45.2.251.","journal-title":"Neurology"},{"key":"9404_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7224\/1537-2073.2012-019","volume":"15","author":"RD Larson","year":"2013","unstructured":"Larson RD. Psychometric properties of the modified fatigue impact scale. Int J MS Care. 2013;15:15\u201320. https:\/\/doi.org\/10.7224\/1537-2073.2012-019.","journal-title":"Int J MS Care"},{"key":"9404_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ageing\/afp225","volume":"39","author":"K Delbaere","year":"2010","unstructured":"Delbaere K, et al. The Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study. Age Ageing. 2010;39:210\u20136. https:\/\/doi.org\/10.1093\/ageing\/afp225.","journal-title":"Age Ageing"},{"key":"9404_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0164027504268574","volume":"26","author":"ME Hughes","year":"2004","unstructured":"Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT. A short scale for measuring loneliness in large surveys: results from two population-based studies. Res Aging. 2004;26:655\u201372. https:\/\/doi.org\/10.1177\/0164027504268574.","journal-title":"Res Aging"},{"key":"9404_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jclinepi.2006.06.008","volume":"60","author":"K Schultz-Larsen","year":"2007","unstructured":"Schultz-Larsen K, Lomholt RK, Kreiner S. Mini-mental status examination: a short form of MMSE was as accurate as the original MMSE in predicting dementia. J Clin Epidemiol. 2007;60:260\u20137. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.06.008.","journal-title":"J Clin Epidemiol"},{"key":"9404_CR39","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal-D-17-00088","volume":"2","author":"DA Delgado","year":"2018","unstructured":"Delgado DA, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. JAAOS: Global Research and Reviews. 2018;2:e088. https:\/\/doi.org\/10.5435\/JAAOSGlobal-D-17-00088.","journal-title":"JAAOS: Global Research and Reviews"},{"issue":"5","key":"9404_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. <article-title update=\"added\">Eq-sd: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337\u201343. https:\/\/doi.org\/10.3109\/07853890109002087.","journal-title":"Ann Med"},{"key":"9404_CR41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jclinepi.2004.10.018","volume":"58","author":"DL Groll","year":"2005","unstructured":"Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58:595\u2013602. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.10.018.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"9404_CR42","doi-asserted-by":"publisher","first-page":"M209","DOI":"10.1093\/gerona\/57.4.M209","volume":"57","author":"AM Jette","year":"2002","unstructured":"Jette AM, et al. Late Life Function and Disability Instrument: i. Development and evaluation of the disability component. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2002;57(4):M209\u201316. https:\/\/doi.org\/10.1093\/gerona\/57.4.M209.","journal-title":"The Journals of Gerontology Series A: Biological Sciences and Medical Sciences"},{"key":"9404_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12966-025-01851-3","volume":"22","author":"J Buekers","year":"2025","unstructured":"Buekers J, et al. Digital assessment of real-world walking in people with impaired mobility: how many hours and days are needed? Int J Behav Nutr Phys Act. 2025;22:148. https:\/\/doi.org\/10.1186\/s12966-025-01851-3.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"9404_CR44","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s13063-022-06588-z","volume":"23","author":"T Williams","year":"2022","unstructured":"Williams T, et al. Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials. Trials. 2022;23:644. https:\/\/doi.org\/10.1186\/s13063-022-06588-z.","journal-title":"Trials"},{"key":"9404_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000036.pub2","author":"NJ Preston","year":"2016","unstructured":"Preston NJ, et al. Strategies designed to help healthcare professionals to recruit participants to research studies. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.MR000036.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"9404_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000013.pub5","author":"S Treweek","year":"2010","unstructured":"Treweek S, et al. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev. 2010. https:\/\/doi.org\/10.1002\/14651858.MR000013.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"9404_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/b978-0-444-52001-2.00010-8","volume":"122","author":"DS Goodin","year":"2014","unstructured":"Goodin DS. The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol. 2014;122:231\u201366. https:\/\/doi.org\/10.1016\/b978-0-444-52001-2.00010-8.","journal-title":"Handb Clin Neurol"},{"key":"9404_CR48","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1352458512451510","volume":"19","author":"M Tutuncu","year":"2013","unstructured":"Tutuncu M, et al. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler. 2013;19:188\u201398. https:\/\/doi.org\/10.1177\/1352458512451510.","journal-title":"Mult Scler"},{"key":"9404_CR49","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1093\/brain\/awad218","volume":"146","author":"S Sharmin","year":"2023","unstructured":"Sharmin S, et al. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Brain. 2023;146:4633\u201344. https:\/\/doi.org\/10.1093\/brain\/awad218.","journal-title":"Brain"},{"key":"9404_CR50","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1186\/s13063-022-07004-2","volume":"23","author":"V Daitch","year":"2022","unstructured":"Daitch V, et al. Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis. Trials. 2022;23:1038. https:\/\/doi.org\/10.1186\/s13063-022-07004-2.","journal-title":"Trials"},{"key":"9404_CR51","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/13524585231189670","volume":"29","author":"M Finlayson","year":"2023","unstructured":"Finlayson M, Al-Mashita L, Sandhu R. Participant diversity in clinical trials of rehabilitation interventions for people with multiple sclerosis: a scoping review. Mult Scler. 2023;29:1149\u201357. https:\/\/doi.org\/10.1177\/13524585231189670.","journal-title":"Mult Scler"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09404-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:43:03Z","timestamp":1769064183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09404-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9404"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09404-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) is the sponsor for the entire study. NuTH is responsible for ensuring appropriate regulatory and ethical approvals are in place at all participating sites. Ethical approval was issued for all sites by: Ethical Commission (EC) of the Medical Faculty of Friedrich-Alexander University Erlangen-N\u00fcrnberg (Erlangen-N\u00fcrnberg, vote 535_20 B); EC of the Medical Faculty of Christian-Albrechts-University Kiel (Kiel; vote D 630\/20); EC dell\u2019Insubria (Milan; vote 196 del 2021); London-Bloomsbury Research Ethics Committee (Sheffield; vote 20\/PR\/0792).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No competing interests; all authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}